Basic Information
| LncRNA/CircRNA Name | PTCSC3 |
| Synonyms | NA |
| Region | GRCh38_14:36136108-36176468 |
| Ensemble | ENSG00000259104 |
| Refseq | NR_049735 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | RT-qPCR |
| Sample | gastric cancer cell lines,blood |
| Expression Pattern | down-regulated |
| Function Description | During follow-up, patients with low plasma levels of PTCSC3 showed a significantly lower overall survival rate. PTCSC3 negatively regulated proliferation, invasion, and migration of gastric cancer cells. |
| Pubmed ID | 31702383 |
| Year | 2019 |
| Title | LncRNA PTCSC3 Is a Biomarker for the Treatment and Prognosis of Gastric Cancer |
External Links
| Links for PTCSC3 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |